Prescient Medical

Prescient Medical was a clinical-stage medical device company focused on the detection and treatment of vulnerable plaque, a primary cause of sudden heart attacks. Founded by interventional cardiology pioneers, the company developed advanced diagnostic imaging and interventional tools, including the vProtect Luminal Shield and the vScan imaging catheter. The company's technology utilized Raman spectroscopy and other imaging modalities to identify high-risk atherosclerotic lesions before they ruptured. Despite significant venture capital backing and participation in major clinical trials like PROSPECT, the company is no longer active in the market.